Race is on to deliver coronavirus vaccine
MELBOURNE: As countries shut their doors to overseas visitors in a bid to stop the spread of coronavirus, Australian scientists are at the forefront of a global push to find a vaccine without borders.
Teams of scientists across the world are working around the clock to either develop a new drug or repurpose an existing medication to halt the spread of the virus.
This quest for a vaccine for COVID-19 is proceeding at a spectacular pace with some scientists skipping animal trials as they race to find a way of halting the terrifying death toll.
Scientists, academics and medical journals are freely sharing early results of clinical trials before they are peer reviewed to progress research as quickly as possible.
But how close are we to a vaccine?
Even with sidestepping normal procedures such as initially testing on animals – it is expected it will take 12-18 months to find a vaccine.
CHINA
The first country to experience the virus and also the first to start searching for vaccines and cures, China is understandably leading the field in the hunt for a vaccine.
To create an original vaccine, the Chinese company Beijing Advaccine Biotechnology is working with a US biotech company called Inovio Pharmaceuticals. They are in the process of developing a “DNA vaccine” called INO-4800.
This vaccine is already in preclinical trial. It involves directly injecting genetic material into a person to trigger a stronger immune response, so they are better equipped to stop an infection.
UNITED STATES
The first human trial of a COVID-19 vaccine began in the US this week with four people injected with a low dose of a vaccine developed by US company Moderna even before animal trials had started.
The initial trial is expected to involve 45 healthy adult volunteers between the ages of 18 and 55 years over approximately six weeks. It could take 12 months before any concrete results are produced.
AUSTRALIA
Researchers at Queensland University are hoping to begin animal trials of its COVID-19 vaccine next month.
The trials will take place at CSIRO’S Geelong laboratory.
Griffith University announced on Thursday it has signed a memorandum of understanding with Queensland-based Luina Bio to work on a vaccine against the virus.
Also,
Australian scientists from University of Queensland began a clinical trial of a treatment they claim could “cure” COVID-19.
The first human clinical trial began for a vaccine and several new blood tests for the virus that take just 10 minutes to produce a result were launched this week.
TREATMENT
AUSTRALIA
Later this month, coronavirus patients in 50 Australian hospitals will be given two drugs used to treat malaria and HIV AIDS in a clinical trial that promises to “cure” the virus.
University of Queensland Centre for Clinical Research Director Professor David Paterson, who is running the trial, said the drugs were shown to be effective against the virus in test tubes and Australian patients given the medications completely cleared the virus.
“These medications have the potential to be a real cure for all, unlike the random anecdotal experiences of some people,” he said.
The medication being used in the trial are HIV treatment Kaletra and malaria treatment Hydroxychloroquine.
A Chinese study involving 200 people reported this week that Kaletra did not work.
Patients given Kaletra had no better outcomes and similar death rates to people who were not given the drug.
FRANCE
Meanwhile a French study in 24 patients has found a cheap treatment for malaria hydroxychloroquine appears to works against COVID-19 especially when combined with an antibiotic azithromycin used to treat bacterial lung disease.
Twenty five per cent of patients who received the drugs tested positive for the virus after six days, compared with 90 per cent of those who did not receive it.
JAPAN
Japan’s Fujifilm – yes the photographic company – also makes a drug called Favipiravir. This was initially intended to treat new strains of the flu. However, it appears to be proving effective in treating coronavirus patients, particularly those with lighter symptoms.
CHINA
In a Chinese trial involving 340 people, the virus cleared up in just four days in those who received the drug, versus 11 days in those who did not receive it.
Multiple trials are under way using the experimental broad spectrum antiviral drug HIV medication Remedsivir which works by stopping the virus’s ability to replicate itself.
First results due are due next month but it may need to be administered early to work.
UNITED KINGDOM
UK company Synairgen is trialling interferon beta, an immune system molecule that is part of the lung’s natural defence system against viruses to combat COVID-19.
Other clinical trials are using blood plasma from patients who have recovered from the virus which is then injected into sick patients to jump start their own immune response.
US company Regeneron is working on isolating the active parts of the plasma to turn it into a drug.






